Physician profile
Ali Yousufuddin
NPI 1083607840
$7,043.80
in general payments reported to CMS, 2019-2025
16 companies · $814 in 2025
The $814 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,166 · 2020: $833 · 2021: $609 · 2022: $1,248 · 2023: $1,672 · 2024: $702 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,188.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,096.05 | 2019-2025 | Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Pfizer INC. | $522.01 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $330.86 | 2019-2025 | Belbuca, Xtampza |
| Scilex Pharmaceuticals INC. | $267.18 | 2019-2024 | Ztlido |
| Daiichi Sankyo INC. | $248.89 | 2019 | |
| Biodelivery Sciences International, INC. | $179.89 | 2019-2021 | |
| Averitas Pharma INC. | $85.43 | 2023-2025 | Qutenza |
| Astrazeneca Pharmaceuticals LP | $65.65 | 2019-2024 | Airsupra |
| Forte Bio-Pharma LLC | $47.91 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.07 | 2019-2020 | |
| Ibsa Pharma INC. | $37.93 | 2021 | |
| Protega Pharmaceutials INC | $36.36 | 2022-2023 | Roxybond |
| Vertex Pharmaceuticals Incorporated | $25.27 | 2025 | |
| Pacira Therapeutics, INC. | $21.84 | 2019 | |
| Assertio Therapeutics, INC. | $20.07 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Yousufuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.